Association among Fibrinolytic Proteins, Metabolic Syndrome Components, Insulin Secretion, and Resistance in Schoolchildren

Figure 2

(a) Urokinase plasminogen activator (uPA), (b) soluble urokinase plasminogen activator receptor (suPAR), and (c) plasminogen activator inhibitor-1 (PAI-1) in children with and without metabolic syndrome (MetS). The uPA and suPAR levels are not significantly different between children with and without MetS. However, children with MetS have higher PAI-1 levels. Mean ± SE; .

(a)

(b)

(c)